Summers Labs (as Pld) - Keralyt Gel 3% Salicylic Acid (11086-038)

Summers Labs (as Pld) - Keralyt Gel 3% Salicylic Acid (11086-038)
SPL v7
SPL
SPL Set ID c02018de-3b03-49b7-9152-c65b248345ad
Route
TOPICAL
Published
Effective Date 2013-10-30
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Salicylic Acid (3 g)
Inactive Ingredients
Propylene Glycol Alcohol Hydroxypropyl Cellulose Water

Identifiers & Packaging

Marketing Status
OTC MONOGRAPH DRUG Active Since 2013-10-30
Description

ACTIVE INGREDIENT SALICYLIC ACID 3%

Medication Information

Warnings and Precautions

WARNINGS

FOR EXTERNAL USE ONLY

Indications and Usage

USES

HELPS STOP THESE SYMPTOMS OF PSORIASIS, SEBORRHEIC DERMATITIS AND DANDRUFF

  • FLAKING
  • SCALING
  • REDNESS
  • IRRITATION
  • ITCHING
Dosage and Administration

DIRECTIONS

  • APPLY TO AFFECTED AREA ONE TO FOUR TIMES DAILY OR AS DIRECTED BY A DOCTOR.
Description

ACTIVE INGREDIENT SALICYLIC ACID 3%

Section 50565-1

KEEP OUT OF REACH OF CHILDREN. IN CASE OF ACCIDENTAL INGESTION, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

Section 50566-9

STOP USE AND CONSULT A DOCTOR IF CONDITION WORSENS OR DOES NOT IMPROVE AFTER REGULAR USE.

Section 50567-7

WHEN USING THIS PRODUCT

  • DO NOT GET INTO EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER. IF IRRITATION PERSISTS, CONSULT A DOCTOR.
Section 50569-3

ASK A DOCTOR BEFORE USE IF CONDITION COVERS A LARGE AREA OF THE BODY

Section 51727-6

INACTIVE INGREDIENTS

PROPYLENE GLYCOL, SD-40 ALCOHOL (21%), WATER, HYDROXYPROPYLCELLULOSE

Section 51945-4

Section 55105-1

PURPOSE

PSORIASIS, SEBORRHEIC DERMATITIS

Section 55106-9

ACTIVE INGREDIENT

SALICYLIC ACID 3%

Section 60561-8

FLAMMABLE

Structured Label Content

Indications and Usage (34067-9)

USES

HELPS STOP THESE SYMPTOMS OF PSORIASIS, SEBORRHEIC DERMATITIS AND DANDRUFF

  • FLAKING
  • SCALING
  • REDNESS
  • IRRITATION
  • ITCHING
Dosage and Administration (34068-7)

DIRECTIONS

  • APPLY TO AFFECTED AREA ONE TO FOUR TIMES DAILY OR AS DIRECTED BY A DOCTOR.
Warnings and Precautions (34071-1)

WARNINGS

FOR EXTERNAL USE ONLY

Section 50565-1 (50565-1)

KEEP OUT OF REACH OF CHILDREN. IN CASE OF ACCIDENTAL INGESTION, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

Section 50566-9 (50566-9)

STOP USE AND CONSULT A DOCTOR IF CONDITION WORSENS OR DOES NOT IMPROVE AFTER REGULAR USE.

Section 50567-7 (50567-7)

WHEN USING THIS PRODUCT

  • DO NOT GET INTO EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER. IF IRRITATION PERSISTS, CONSULT A DOCTOR.
Section 50569-3 (50569-3)

ASK A DOCTOR BEFORE USE IF CONDITION COVERS A LARGE AREA OF THE BODY

Section 51727-6 (51727-6)

INACTIVE INGREDIENTS

PROPYLENE GLYCOL, SD-40 ALCOHOL (21%), WATER, HYDROXYPROPYLCELLULOSE

Section 51945-4 (51945-4)

Section 55105-1 (55105-1)

PURPOSE

PSORIASIS, SEBORRHEIC DERMATITIS

Section 55106-9 (55106-9)

ACTIVE INGREDIENT

SALICYLIC ACID 3%

Section 60561-8 (60561-8)

FLAMMABLE

Advanced Ingredient Data

Raw Label Data

All Sections (JSON)

Additional Information

Back to search View SPL set listing Open on DailyMed ↗

Source: dailymed · Ingested: 2026-02-15T12:01:20.884713 · Updated: 2026-03-14T23:01:22.645369